Ropes & Gray represented preclinical and clinical bioanalysis company Dash Bio in the company’s latest financing round, in which it raised $11 million, bringing its total raised to $17.5 million. The latest round was announced in a July 23 press release and covered in The Wall Street Journal’s Venture Capital Pro publication.
Dash Bio accelerates clinical development by delivering high-quality, technology-driven bioanalysis at unprecedented speed. Its fully automated, GLP-compliant lab platform combines robotics, AI, and integrated software to deliver faster results and better data — helping biopharma teams get therapies to patients faster.
The team was led by emerging companies & venture capital partner Brad Flint and emerging companies & venture capital associate Joe Muller.
Attorneys
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.